Correlation Between China Asset and Cansino Biologics

Can any of the company-specific risk be diversified away by investing in both China Asset and Cansino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Asset and Cansino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between China Asset Management and Cansino Biologics, you can compare the effects of market volatilities on China Asset and Cansino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Asset with a short position of Cansino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Asset and Cansino Biologics.

Diversification Opportunities for China Asset and Cansino Biologics

0.16

Correlation Coefficient

China Asset  Cansino Biologics

Average diversification

The 3 months correlation between China and Cansino is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding China Asset Management and Cansino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cansino Biologics and China Asset is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Asset Management are associated (or correlated) with Cansino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cansino Biologics has no effect on the direction of China Asset i.e., China Asset and Cansino Biologics go up and down completely randomly.

Pair Corralation between China Asset and Cansino Biologics

Assuming the 90 days trading horizon China Asset Management is expected to generate 0.57 times more return on investment than Cansino Biologics. However, China Asset Management is 1.75 times less risky than Cansino Biologics. It trades about 0.58 of its potential returns per unit of risk. Cansino Biologics is currently generating about -0.24 per unit of risk. If you would invest  318.00  in China Asset Management on October 6, 2024 and sell it today you would earn a total of  53.00  from holding China Asset Management or generate 16.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

China Asset Management  vs.  Cansino Biologics

China Asset Management

Risk-Adjusted Performance

20 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in China Asset Management are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, China Asset sustained solid returns over the last few months and may actually be approaching a breakup point.

Cansino Biologics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cansino Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Cansino Biologics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with China Asset and Cansino Biologics

The main advantage of trading using opposite China Asset and Cansino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Asset position performs unexpectedly, Cansino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cansino Biologics will offset losses from the drop in Cansino Biologics' long position.

The idea behind China Asset Management and Cansino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.